Changes coming to weight loss drug coverage benefits, effective January 1, 2025 Effective January 1, 2025, Independence Blue Cross (IBX) will no longer offer coverage for drugs including glucagon-like peptide-1 receptor antagonist (GLP-1) and non-glucagon-like peptide-1 receptor antagonist (non-GLP-1) indicated for and prescribed solely for weight loss in the absence of other FDA-approved clinical indications
Creatine has hundreds of research studies proving its effectiveness in increasing strength, power, endurance, and muscle hypertrophy in athletes, bodybuilders, and gym-goers alike
At Nasseri Clinic of Arthritic and Rheumatic Diseases, providers offer a range of customized IV fluid therapy plans that address each patients unique health needs
We created this guide to help you learn more about what they are, how to get started and what to expect if your doctor prescribes a GLP-1 for you